How Trump’s Greenland Plan Could Hit Ozempic, Legos and Hearing Aids
Published On Jan 8, 2025, 12:22 PM
President-elect Donald Trump threatens high tariffs on Denmark if the country does not cede Greenland to the U.S. This could lead to increased prices for key Danish products, particularly medicines from Novo Nordisk, which manufactures popular drugs like Ozempic and Wegovy. With Denmark relying heavily on pharmaceutical exports, any tariff could have significant implications for U.S. consumers and the profitability of companies like Novo Nordisk.
Stock Forecasts
NVO
Neutral
The potential tariffs could disrupt the supply chain for Novo Nordisk’s pharmaceuticals, impacting revenue and stock performance. Given the essential nature of these medications and their popularity, there may be pushback from the public and healthcare sector, potentially stabilizing the stock despite initial volatility.
Related News
Stock market today: Dow, S&P 500, Nasdaq rebound on fresh inflation data to cap volatile week
Dec 20, 2024, 4:14 PM
Stocks signaled another rough day of trading on Friday after the House of Representatives voted against a Trump-backed spending bill.
Novo Nordisk stock sees biggest loss in more than 20 years on CagriSema results
Dec 20, 2024, 11:09 AM
Novo Nordisk stock sinks on news of its newest GLP-1 candidate.
Stock market today: Dow, S&P 500, Nasdaq rebound as inflation data improves
Dec 20, 2024, 11:09 AM
Stocks signaled another rough day of trading on Friday after the House of Representatives voted against a Trump-backed spending bill.